申请人:Seattle Genetics, Inc.
公开号:EP2842575A1
公开(公告)日:2015-03-04
Drug Linker compounds and Drug Linker Ligand conjugates are provided that have auristatins linked via the C-terminus. The conjugates show efficacy without the need for a self-immolative group to release the drug.
本研究提供的药物连接体化合物和药物连接体配体共轭物具有通过 C 端连接的呋喃妥因。这些共轭物无需自巯基释放药物即可显示出药效。